Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Ovarian Neoplasms 14Carcinoma, Ovarian Epithelial 11Fallopian Tube Neoplasms 10Uterine Cervical Neoplasms 9Endometrial Neoplasms 5Peritoneal Neoplasms 3Sarcoma 2Brenner Tumor 2Vomiting 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pheochromocytoma 1Paget's Disease, Mammary 1Ovarian Germ Cell Cancer 1Neutropenia 1Neurofibrosarcoma 1Nausea 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1High-risk Endometrial Cancer 1Hemangiosarcoma 1

Interventions

Doxorubicin 4Ifosfamide 3Filgrastim 3Radiotherapy 2Imatinib Mesylate 2brostallicin 1Vincristine 1Trabectedin 1Temozolomide 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Mass Spectrometry 1Etoposide 1Epirubicin 1Dactinomycin 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Carboplatin 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant mesenchymal tumor × Chemotherapy, Adjuvant × Gynecologic × Clear all
NCT00002641 2014-08-08

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
350 enrolled
EndocrineGenitourinaryGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Kidney Neoplasms, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Pheochromocytoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡